Virginie Lemiale1, Matthieu Resche-Rigon, Djamel Mokart, Frédéric Pène, Laurent Argaud, Julien Mayaux, Christophe Guitton, Antoine Rabbat, Christophe Girault, Achille Kouatchet, François Vincent, Fabrice Bruneel, Martine Nyunga, Amélie Seguin, Kada Klouche, Gwenahel Colin, Loay Kontar, Pierre Perez, Anne-Pascale Meert, Dominique D Benoit, Laurent Papazian, Alexandre Demoule, Sylvie Chevret, Elie Azoulay. 1. 1Medical ICU, Saint Louis Teaching Hospital, Paris, France. 2Biostatistics department, Saint Louis Teaching Hospital, Paris, France. 3Medical and surgical ICU, Paoli Calmettes Institut Marseilles, France. 4Medical ICU, Cochin Teaching Hospital, Paris, France. 5Medical and surgical ICU, Edouard Herriot Teaching hospital, Lyon, France. 6Medical ICU, Pitié-Salpétrière Teaching Hospital, Paris, France. 7Medical ICU, Hotel Dieu Teaching hospital, Nantes, France. 8Medical ICU, Respiratory Unit, Cochin Teaching Hospital, Paris, France. 9Medical ICU, C Nicolle Hospital, Rouen, France. 10Medical ICU, Angers Teaching Hospital, Angers, France. 11Medical and surgical ICU, Montfermeil Hospital, Montfermeil. France. 12Medical ICU, Mignot Hospital, Versailles, France. 13Medical and surgical ICU, Roubaix Hospital, France. 14Medical ICU, Caen Teaching Hospital, Caen, France. 15Medical ICU, Montpellier Teaching Hospital, Montpellier, France. 16Medical ICU, La Roche sur Yon Hospital, La Roche Sur Yon, France. 17Medical ICU, Amiens Teaching Hospital, Amiens, France. 18Medical ICU, Brabois Teaching Hospital, Nancy, France. 19Medical ICU, Institut J Bordet, Bruxelles, Belgium. 20Medical ICU, Ghent University Hospital, Ghent, Belgium. 21Hôpitaux de Marseille, Hôpital Nord, Réanimation des Détresses Respiratoires et des Infections Sévères, Marseille, France. 22Aix-Marseille Université, Faculté de médecine, URMITE UMR CNRS 7278, Marseille, France.
Abstract
OBJECTIVE: In immunocompromised patients with acute respiratory failure, invasive mechanical ventilation remains associated with high mortality. Choosing the adequate oxygenation strategy is of the utmost importance in that setting. High-flow nasal oxygen has recently shown survival benefits in unselected patients with acute respiratory failure. The objective was to assess outcomes of immunocompromised patients with hypoxemic acute respiratory failure treated with high-flow nasal oxygen. DESIGN: We performed a post hoc analysis of a randomized controlled trial of noninvasive ventilation in critically ill immunocompromised patients with hypoxemic acute respiratory failure. SETTING:Twenty-nine ICUs in France and Belgium. PATIENTS: Critically ill immunocompromised patients with hypoxemic acute respiratory failure. INTERVENTION: A propensity score-based approach was used to assess the impact of high-flow nasal oxygen compared with standard oxygen on day 28 mortality. MEASUREMENTS AND MAIN RESULTS: Among 374 patients included in the study, 353 met inclusion criteria. Underlying disease included mostly malignancies (n = 296; 84%). Acute respiratory failure etiologies were mostly pneumonia (n = 157; 44.4%) or opportunistic infection (n = 76; 21.5%). Noninvasive ventilation was administered to 180 patients (51%). Invasive mechanical ventilation was ultimately needed in 142 patients (40.2%). Day 28 mortality was 22.6% (80 deaths). Throughout the ICU stay, 127 patients (36%) received high-flow nasal oxygen whereas 226 patients received standard oxygen. Ninety patients in each group (high-flow nasal oxygen or standard oxygen) were matched according to the propensity score, including 91 of 180 (51%) who receivednoninvasive ventilation. High-flow nasal oxygen was neither associated with a lower intubation rate (hazard ratio, 0.42; 95% CI, 0.11-1.61; p = 0.2) nor day 28 mortality (hazard ratio, 0.80; 95% CI, 0.45-1.42; p = 0.45). CONCLUSIONS: In immunocompromised patients with hypoxemic acute respiratory failure, high-flow nasal oxygen when compared with standard oxygen did not reduce intubation or survival rates. However, these results could be due to low statistical power or unknown confounders associated with the subgroup analysis. A randomized trial is needed.
RCT Entities:
OBJECTIVE: In immunocompromised patients with acute respiratory failure, invasive mechanical ventilation remains associated with high mortality. Choosing the adequate oxygenation strategy is of the utmost importance in that setting. High-flow nasal oxygen has recently shown survival benefits in unselected patients with acute respiratory failure. The objective was to assess outcomes of immunocompromised patients with hypoxemic acute respiratory failure treated with high-flow nasal oxygen. DESIGN: We performed a post hoc analysis of a randomized controlled trial of noninvasive ventilation in critically ill immunocompromised patients with hypoxemic acute respiratory failure. SETTING: Twenty-nine ICUs in France and Belgium. PATIENTS: Critically ill immunocompromised patients with hypoxemic acute respiratory failure. INTERVENTION: A propensity score-based approach was used to assess the impact of high-flow nasal oxygen compared with standard oxygen on day 28 mortality. MEASUREMENTS AND MAIN RESULTS: Among 374 patients included in the study, 353 met inclusion criteria. Underlying disease included mostly malignancies (n = 296; 84%). Acute respiratory failure etiologies were mostly pneumonia (n = 157; 44.4%) or opportunistic infection (n = 76; 21.5%). Noninvasive ventilation was administered to 180 patients (51%). Invasive mechanical ventilation was ultimately needed in 142 patients (40.2%). Day 28 mortality was 22.6% (80 deaths). Throughout the ICU stay, 127 patients (36%) received high-flow nasal oxygen whereas 226 patients received standard oxygen. Ninety patients in each group (high-flow nasal oxygen or standard oxygen) were matched according to the propensity score, including 91 of 180 (51%) who received noninvasive ventilation. High-flow nasal oxygen was neither associated with a lower intubation rate (hazard ratio, 0.42; 95% CI, 0.11-1.61; p = 0.2) nor day 28 mortality (hazard ratio, 0.80; 95% CI, 0.45-1.42; p = 0.45). CONCLUSIONS: In immunocompromised patients with hypoxemic acute respiratory failure, high-flow nasal oxygen when compared with standard oxygen did not reduce intubation or survival rates. However, these results could be due to low statistical power or unknown confounders associated with the subgroup analysis. A randomized trial is needed.
Authors: Samir Jaber; Giacomo Bellani; Lluis Blanch; Alexandre Demoule; Andrés Esteban; Luciano Gattinoni; Claude Guérin; Nicholas Hill; John G Laffey; Salvatore Maurizio Maggiore; Jordi Mancebo; Paul H Mayo; Jarrod M Mosier; Paolo Navalesi; Michael Quintel; Jean Louis Vincent; John J Marini Journal: Intensive Care Med Date: 2017-08-07 Impact factor: 17.440
Authors: Elie Azoulay; Peter Pickkers; Marcio Soares; Anders Perner; Jordi Rello; Philippe R Bauer; Andry van de Louw; Pleun Hemelaar; Virginie Lemiale; Fabio Silvio Taccone; Ignacio Martin Loeches; Tine Sylvest Meyhoff; Jorge Salluh; Peter Schellongowski; Katerina Rusinova; Nicolas Terzi; Sangeeta Mehta; Massimo Antonelli; Achille Kouatchet; Andreas Barratt-Due; Miia Valkonen; Precious Pearl Landburg; Fabrice Bruneel; Ramin Brandt Bukan; Frédéric Pène; Victoria Metaxa; Anne Sophie Moreau; Virginie Souppart; Gaston Burghi; Christophe Girault; Ulysses V A Silva; Luca Montini; François Barbier; Lene B Nielsen; Benjamin Gaborit; Djamel Mokart; Sylvie Chevret Journal: Intensive Care Med Date: 2017-09-25 Impact factor: 17.440
Authors: Amanda Corley; Claire M Rickard; Leanne M Aitken; Amy Johnston; Adrian Barnett; John F Fraser; Sharon R Lewis; Andrew F Smith Journal: Cochrane Database Syst Rev Date: 2017-05-30
Authors: Elie Azoulay; Peter Schellongowski; Michael Darmon; Philippe R Bauer; Dominique Benoit; Pieter Depuydt; Jigeeshu V Divatia; Virginie Lemiale; Maarten van Vliet; Anne-Pascale Meert; Djamel Mokart; Stephen M Pastores; Anders Perner; Frédéric Pène; Peter Pickkers; Kathryn A Puxty; Francois Vincent; Jorge Salluh; Ayman O Soubani; Massimo Antonelli; Thomas Staudinger; Michael von Bergwelt-Baildon; Marcio Soares Journal: Intensive Care Med Date: 2017-07-19 Impact factor: 17.440
Authors: Leila Taheri; Rathai Anandanadesan; Hugues de Lavallade; Eirini Pagkalidou; Antonio Pagliuca; Ghulam Mufti; Georg Auzinger; Victoria Metaxa Journal: J Intensive Care Soc Date: 2019-06-10
Authors: Courtney M Rowan; Julie C Fitzgerald; Asya Agulnik; Matt S Zinter; Matthew P Sharron; James E Slaven; Erin M Kreml; Rajinder P S Bajwa; Kris M Mahadeo; Jerelyn Moffet; Keiko M Tarquinio; Marie E Steiner Journal: Front Oncol Date: 2021-05-27 Impact factor: 6.244